Restylane Lyft with Lido (1x1 ml)

Patients should avoid alcohol for 24h before and 48h after the procedure. Alcohol is a vasodilator that can increase post-filler swelling and worsen bruising at the deep entry points required for mid-face contouring.

Injection is not recommended for nursing mothers. It is advised to postpone elective volumizing treatments until the breastfeeding period has completely concluded.

The formulation contains 20 mg/ml of NASHA cross-linked Hyaluronic Acid of non-animal origin and 0.3% Lidocaine hydrochloride.

Dosage is individualized based on the patient's anatomical volume deficit. Typically, 1 ml to 2 ml is used for bilateral cheek augmentation. For the hands, 1 ml per hand is a common starting point. Practitioners should evaluate if subtle structural support is achieved before utilizing multiple syringes for high-projection goals.

Expect temporary swelling, tenderness, and potential purple bruising at the deep injection site. Because of its firmness, localized pressure may be felt for 3–5 days. Follow our expert aftercare guide for optimal recovery. Any persistent blanching requires immediate evaluation for vascular occlusion.

Lyft utilizes a highly cross-linked HA matrix with a large particle size to act as a structural scaffold in the deep dermis or supraperiosteal layer. Unlike skin boosters, which focus on hydration, Restylane Lyft provides the high G-prime necessary for mechanical "lifting" and bone-mimicking projection.

This treatment is strictly contraindicated. No clinical safety data exists for high-density HA volumizers during pregnancy. We defer elective aesthetic procedures until after childbirth to ensure the highest safety standards.